Understanding How Cells Die in Diseases
Molecular Mechanisms of Programmed Necrosis Execution
This project explores how cells die in a specific way called necroptosis, which is important in conditions like cancer and infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11143785 on NIH RePORTER |
What this research studies
Necroptosis is a type of cell death that plays a role in many human diseases, including various cancers, inflammatory bowel disease, liver injury, and infections like COVID-19. This work focuses on understanding the exact steps of this cell death process, particularly how a molecule called MLKL causes cells to rupture. By learning how MLKL is activated and regulated, researchers hope to find ways to control this process. This foundational knowledge could lead to new treatments for diseases where too much or too little necroptosis is a problem.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but future clinical applications could benefit patients with cancer, inflammatory bowel disease, neurodegenerative disorders, or severe infections.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this basic science project.
Why it matters
Potential benefit: If successful, this work could lead to new ways to stop or encourage cell death, offering new treatment strategies for a wide range of diseases.
How similar studies have performed: While the general concept of programmed cell death is well-established, the specific molecular mechanisms regulating MLKL activation in necroptosis are still being uncovered, making this a novel area of focus.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Najafov, Ayaz — Ut Southwestern Medical Center
- Study coordinator: Najafov, Ayaz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.